Literature DB >> 28589520

Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.

Eun-Joo Shin1, Hai-Quyen Tran1, Phuong-Tram Nguyen1, Ji Hoon Jeong2, Seung-Yeol Nah3, Choon-Gon Jang4, Toshitaka Nabeshima5, Hyoung-Chun Kim6.   

Abstract

Methamphetamine (MA), an amphetamine-type psychostimulant, is associated with dopaminergic toxicity and has a high abuse potential. Numerous in vivo and in vitro studies have suggested that impaired mitochondria are critical in dopaminergic toxicity induced by MA. Mitochondria are important energy-producing organelles with dynamic nature. Evidence indicated that exposure to MA can disturb mitochondrial energetic metabolism by inhibiting the Krebs cycle and electron transport chain. Alterations in mitochondrial dynamic processes, including mitochondrial biogenesis, mitophagy, and fusion/fission, have recently been shown to contribute to dopaminergic toxicity induced by MA. Furthermore, it was demonstrated that MA-induced mitochondrial impairment enhances susceptibility to oxidative stress, pro-apoptosis, and neuroinflammation in a positive feedback loop. Protein kinase Cδ has emerged as a potential mediator between mitochondrial impairment and oxidative stress, pro-apoptosis, or neuroinflammation in MA neurotoxicity. Understanding the role and underlying mechanism of mitochondrial impairment could provide a molecular target to prevent or alleviate dopaminergic toxicity induced by MA.

Entities:  

Keywords:  Apoptosis; Dopaminergic toxicity; Methamphetamine; Mitochondria; Protein kinase Cδ

Mesh:

Substances:

Year:  2017        PMID: 28589520     DOI: 10.1007/s11064-017-2318-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  153 in total

1.  Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase.

Authors:  W F Maragos; R Jakel; D Chesnut; C B Pocernich; D A Butterfield; D St Clair; W A Cass
Journal:  Brain Res       Date:  2000-09-29       Impact factor: 3.252

2.  Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells.

Authors:  Amornpan Ajjimaporn; John Swinscoe; Shaik Shavali; Piyarat Govitrapong; Manuchair Ebadi
Journal:  Brain Res Bull       Date:  2005-08-30       Impact factor: 4.077

3.  Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.

Authors:  Jannine G Truong; Diana G Wilkins; Jakub Baudys; Dennis J Crouch; Kamisha L Johnson-Davis; James W Gibb; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2005-05-18       Impact factor: 4.030

4.  Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.

Authors:  Alvaro Hermida-Ameijeiras; Estefanía Méndez-Alvarez; Sofía Sánchez-Iglesias; Carolina Sanmartín-Suárez; Ramón Soto-Otero
Journal:  Neurochem Int       Date:  2004-07       Impact factor: 3.921

Review 5.  Mitochondria and Cancer.

Authors:  Wei-Xing Zong; Joshua D Rabinowitz; Eileen White
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

6.  CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat.

Authors:  Irina N Krasnova; Margarit Chiflikyan; Zuzana Justinova; Michael T McCoy; Bruce Ladenheim; Subramaniam Jayanthi; Cynthia Quintero; Christie Brannock; Chanel Barnes; Jordan E Adair; Elin Lehrmann; Firas H Kobeissy; Mark S Gold; Kevin G Becker; Steven R Goldberg; Jean Lud Cadet
Journal:  Neurobiol Dis       Date:  2013-05-30       Impact factor: 5.996

7.  Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.

Authors:  J P O'Callaghan; D B Miller
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

8.  Why is parkinsonism not a feature of human methamphetamine users?

Authors:  Anna Moszczynska; Paul Fitzmaurice; Lee Ang; Kathryn S Kalasinsky; Gregory A Schmunk; Frank J Peretti; Sally S Aiken; Dennis J Wickham; Stephen J Kish
Journal:  Brain       Date:  2003-11-25       Impact factor: 13.501

9.  Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.

Authors:  David M Thomas; Paul D Walker; Joyce A Benjamins; Timothy J Geddes; Donald M Kuhn
Journal:  J Pharmacol Exp Ther       Date:  2004-05-26       Impact factor: 4.030

10.  Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways.

Authors:  Genevieve Beauvais; Kenisha Atwell; Subramaniam Jayanthi; Bruce Ladenheim; Jean Lud Cadet
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

View more
  22 in total

1.  Bilateral Basal Ganglia Necrosis Secondary to Methamphetamine.

Authors:  Andrea Sanchez; Irene A Malaty; Anna Khanna; Katharina Busl; Teddy S Youn; Nandakumar Nagaraja; Wissam Deeb; Matthew McAdams; Michael S Okun; Daniel Martinez-Ramirez
Journal:  Mov Disord Clin Pract       Date:  2018-08-02

Review 2.  Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies.

Authors:  Milky Kohno; Jeanne Link; Laura E Dennis; Holly McCready; Marilyn Huckans; William F Hoffman; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2019-01-26       Impact factor: 3.533

3.  Effect of methamphetamine on the fasting blood glucose in methamphetamine abusers.

Authors:  Yanhong Zhang; Guofang Shu; Ying Bai; Jie Chao; Xufeng Chen; Honghong Yao
Journal:  Metab Brain Dis       Date:  2018-06-26       Impact factor: 3.584

Review 4.  The Crosstalk Between Neurons and Glia in Methamphetamine-Induced Neuroinflammation.

Authors:  Sai Shi; Tianzhen Chen; Min Zhao
Journal:  Neurochem Res       Date:  2022-01-04       Impact factor: 3.996

Review 5.  Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn.

Authors:  Deepika Sankaran; Satyan Lakshminrusimha; Veena Manja
Journal:  J Perinatol       Date:  2021-11-16       Impact factor: 2.521

6.  Effect of rottlerin on astrocyte phenotype polarization after trimethyltin insult in the dentate gyrus of mice.

Authors:  Yeonggwang Hwang; Hyoung-Chun Kim; Eun-Joo Shin
Journal:  J Neuroinflammation       Date:  2022-06-11       Impact factor: 9.587

Review 7.  Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yeonggwang Hwang; Naveen Sharma; Duy-Khanh Dang; Bao-Trong Nguyen; Seung-Yeol Nah; Choon-Gon Jang; Guoying Bing; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2021-07-20       Impact factor: 4.946

Review 8.  The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment.

Authors:  Xue Yang; Yong Wang; Qiyan Li; Yaxian Zhong; Liangpei Chen; Yajun Du; Jing He; Lvshuang Liao; Kun Xiong; Chun-Xia Yi; Jie Yan
Journal:  Front Mol Neurosci       Date:  2018-06-04       Impact factor: 5.639

Review 9.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

10.  A genetic polymorphism that is associated with mitochondrial energy metabolism increases risk of fibromyalgia.

Authors:  Miranda A L van Tilburg; Marc Parisien; Richard G Boles; Gillian L Drury; Julian Smith-Voudouris; Vivek Verma; Samar Khoury; Anne-Julie Chabot-Doré; Andrea G Nackley; Shad B Smith; William E Whitehead; Denniz A Zolnoun; Gary D Slade; Inna Tchivileva; William Maixner; Luda Diatchenko
Journal:  Pain       Date:  2020-12       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.